Last updated on March 2019

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus


Brief description of study

The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).

Clinical Study Identifier: NCT03616912

Contact Investigators or Research Sites near you

Start Over

Leon H Kircik

DermResearch, PLLC
Louisville, KY United States
3.97miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.